1 drug(s) with this reaction
258 total reports
Infarction has been reported as an adverse reaction across 1 drug(s) manufactured by Abbvie Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 258 adverse event reports mention infarction in connection with Abbvie Inc products.
This page provides a breakdown of which Abbvie Inc drugs are most commonly associated with infarction, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Abbvie Inc drugs have infarction listed in their FDA adverse event reports, sorted by report count:
In addition to infarction, the following adverse reactions have been reported across Abbvie Inc's drug portfolio:
1 drug(s) manufactured by Abbvie Inc have infarction listed in their FDA adverse event reports: PARICALCITOL.
There are a combined 258 reports of infarction across 1 Abbvie Inc drug(s) in the FDA adverse event database.